Bleakley Financial Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-41,691
| Closed | -$227K | – | 802 |
|
|
2024
Q4 | $227K | Buy |
41,691
+9,657
| +30% | +$52.6K | 0.01% | 911 |
|
|
2024
Q3 | $266K | Buy |
32,034
+8,863
| +38% | +$73.7K | 0.01% | 814 |
|
|
2024
Q2 | $166K | Sell |
23,171
-6,442
| -22% | -$46.1K | ﹤0.01% | 914 |
|
|
2024
Q1 | $257K | Buy |
29,613
+5,853
| +25% | +$50.7K | 0.01% | 809 |
|
|
2023
Q4 | $156K | Buy |
23,760
+10,796
| +83% | +$70.7K | ﹤0.01% | 871 |
|
|
2023
Q3 | $130K | Buy |
+12,964
| New | +$130K | ﹤0.01% | 821 |
|